Stipple Bio, Inc. funding

Stipple Bio, Inc., a biotechnology company based in Cambridge, MA (founded 2021), filed a Form D with the SEC on April 6, 2026 and reported $65.1M raised of a $100M offering.

Amount raised$65.1M

Offering size$100M

Filed with the SECApril 6, 2026

First saleMarch 31, 2026

IndustryBiotechnology

SecuritiesEquity

LocationCambridge, MA

Founded2021

Entity typeCorporation

Investors so far15

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Apr 6

Other health care rounds in Massachusetts

Zai Lab Ltd$250M · Nov 9Biotechnology Typewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology AI3 Bio, Inc.$48.3M · Nov 4Biotechnology Nanopath Inc$29.9M · Nov 13Biotechnology XRHealth, Inc.$22.8M · Sep 16Other Health Care Xact Bio, Inc.$10M · Sep 28Biotechnology Crosslink Therapeutics Inc.$5.5M · Oct 20Pharmaceuticals Fresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care